Project Title: A novel therapeutic target in pancreatic cancer: Implications for therapy and diagnosis
Institution: Curtin University
Principal Investigator: Dr Marco Falasca
Position Held: Professor
Time required to complete project: 3 years
Project Summary: The project team have discovered that a protein named GPR55 promotes pancreatic cancer growth. Their preliminary data demonstrates that a GPR55 inhibitor, in combination with a drug used in therapy, is able to increase survival in mice that develop pancreatic cancer. The project team’s plan is to identify more potent drug combinations to treat pancreatic cancer and also identify new marker that will enable to diagnose pancreatic cancer earlier.